当前位置:首页 - 行情中心 - 益盛药业(002566) - 财务分析 - 现金流量表

益盛药业

(002566)

  

流通市值:16.15亿  总市值:23.03亿
流通股本:2.32亿   总股本:3.31亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金374,158,352.6201,484,029.37717,941,855.94519,011,690.96
  收到的税费返还503,829.99232,004.03703,253.65571,542.12
  收到其他与经营活动有关的现金14,535,858.1710,379,069.7419,797,954.9616,139,916.66
  经营活动现金流入小计389,198,040.76212,095,103.14738,443,064.55535,723,149.74
  购买商品、接受劳务支付的现金48,669,582.422,237,359.4486,056,636.3465,603,422.4
  支付给职工以及为职工支付的现金61,547,901.2433,852,466.16127,575,337.3687,882,445.89
  支付的各项税费50,083,883.2723,768,308.1790,474,137.6168,038,842.62
  支付其他与经营活动有关的现金188,823,315.42100,634,563.49335,597,339.39272,649,594.8
  经营活动现金流出小计349,124,682.33180,492,697.26639,703,450.7494,174,305.71
  经营活动产生的现金流量净额40,073,358.4331,602,405.8898,739,613.8541,548,844.03
二、投资活动产生的现金流量:
  收回投资收到的现金451,720,000160,000,000450,000,000450,000,000
  取得投资收益收到的现金11,775,005.872,999,228.6913,015,093.7711,287,510.45
  处置固定资产、无形资产和其他长期资产收回的现金净额--275,210.14594,278.52
  投资活动现金流入小计463,495,005.87162,999,228.69463,290,303.91461,881,788.97
  购建固定资产、无形资产和其他长期资产支付的现金1,707,373.811,195,665.2213,640,591.6413,035,878.5
  投资支付的现金480,000,00050,000,000501,762,177.52450,036,700
  支付其他与投资活动有关的现金--1,303,300-
  投资活动现金流出小计481,707,373.8151,195,665.22516,706,069.16463,072,578.5
  投资活动产生的现金流量净额-18,212,367.94111,803,563.47-53,415,765.25-1,190,789.53
三、筹资活动产生的现金流量:
  取得借款收到的现金330,000,000210,000,000333,000,000348,000,000
  收到其他与筹资活动有关的现金17,400,0007,400,00020,000,000-
  筹资活动现金流入小计347,400,000217,400,000353,000,000348,000,000
  偿还债务支付的现金290,100,000170,000,000355,000,000310,000,000
  分配股利、利润或偿付利息支付的现金32,203,549.792,842,505.8445,607,753.1142,304,293.5
  支付其他与筹资活动有关的现金24,350,984.3417,151,772.65,641,791.155,553,296.05
  筹资活动现金流出小计346,654,534.13189,994,278.44406,249,544.26357,857,589.55
  筹资活动产生的现金流量净额745,465.8727,405,721.56-53,249,544.26-9,857,589.55
四、汇率变动对现金及现金等价物的影响-0.08-0.04164.38-
五、现金及现金等价物净增加额22,606,456.28170,811,690.87-7,925,531.2830,500,464.95
  加:期初现金及现金等价物余额63,554,309.9163,554,309.9171,479,841.1971,479,841.19
  期末现金及现金等价物余额86,160,766.19234,366,000.7863,554,309.91101,980,306.14
补充资料:
  净利润27,828,590.67-28,930,178.16-
  资产减值准备4,143,857.62-5,174,518.61-
  固定资产和投资性房地产折旧17,882,180.51-35,820,571.82-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧17,882,180.51-35,820,571.82-
  无形资产摊销1,341,658.43-2,683,316.86-
  长期待摊费用摊销339,348.69-684,267.45-
  处置固定资产、无形资产和其他长期资产的损失---400,967.64-
  固定资产报废损失166,922.87-303,922.18-
  公允价值变动损失-2,542,771.84-3,824,213.82-
  财务费用5,819,260.38-12,621,806.38-
  投资损失-11,959,776.69--13,350,997.91-
  递延所得税-1,116,852.75--3,130,766.38-
  其中:递延所得税资产减少-1,132,715.56--2,700,146.98-
    递延所得税负债增加15,862.81--430,619.4-
  存货的减少8,769,720.43-43,027,579.96-
  经营性应收项目的减少-10,695,933.25--29,646,137.38-
  经营性应付项目的增加-1,910,788.62-8,005,071.06-
  现金的期末余额86,160,766.19-63,554,309.91-
  减:现金的期初余额63,554,309.91-71,479,841.19-
  现金及现金等价物的净增加额22,606,456.28--7,925,531.28-
公告日期2026-08-252026-04-252026-04-172025-10-27
审计意见(境内)标准无保留意见
TOP↑